We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
+1.51%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$40.7B
AUM Growth
-$514M
(-1.2%)
Cap. Flow
-$612M
Cap. Flow
% of AUM
-1.5%
Top 10 Holdings %
Top 10 Hldgs %
16.55%
Holding
2,385
New
223
Increased
794
Reduced
1,083
Closed
195
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$348M |
| 2 |
LyondellBasell Industries
LYB
|
+$251M |
| 3 |
Pfizer
PFE
|
+$244M |
| 4 |
Fidelity National Information Services
FIS
|
+$179M |
| 5 |
Amcor
AMCR
|
+$121M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Crown Castle
CCI
|
+$427M |
| 2 |
Kimberly-Clark
KMB
|
+$279M |
| 3 |
Procter & Gamble
PG
|
+$253M |
| 4 |
WP
Worldpay, Inc.
WP
|
+$194M |
| 5 |
General Mills
GIS
|
+$185M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.2% |
| 2 | Technology | 14.96% |
| 3 | Financials | 10.74% |
| 4 | Consumer Discretionary | 9.64% |
| 5 | Communication Services | 8.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
426
Endava
DAVA
$158M
| $15.7M | 0.04% |
415,148
| – | – |
|
427
ScottsMiracle-Gro
SMG
$3.27B
| $15.7M | 0.04% |
154,276
+130,390
| +546% | +$13.7M |
|
428
Gossamer Bio
GOSS
$63.4M
| $15.6M | 0.04% |
11,643
| – | – |
|
429
Fortis
FTS
$27.3B
| $15.5M | 0.04% |
365,246
-8,616
| -2% | -$351K |
|
|
OPLN
430
Openlane
OPLN
$4.26B
| $15.4M | 0.04% |
+627,812
| New | +$16.1M |
|
|
PRO
431
DELISTED
PROS Holdings
PRO
| $15.3M | 0.04% |
257,338
+5,908
| +2% | +$398K |
|
432
Jazz Pharmaceuticals
JAZZ
$15.6B
| $15.3M | 0.04% |
119,353
-8,024
| -6% | -$1.08M |
|
433
SoundThinking
SSTI
$77.9M
| $15.2M | 0.04% |
662,148
+132,148
| +25% | +$4.28M |
|
434
Performance Food Group
PFGC
$14B
| $15.2M | 0.04% |
329,343
-214,697
| -39% | -$9.54M |
|
435
Emergent Biosolutions
EBS
$326M
| $15.1M | 0.04% |
289,660
+19,108
| +7% | +$890K |
|
436
Hancock Whitney
HWC
$6.09B
| $15.1M | 0.04% |
395,202
-133,931
| -25% | -$5.09M |
|
437
Boston Beer
SAM
$1.76B
| $15.1M | 0.04% |
41,466
+26,668
| +180% | +$10.5M |
|
|
WNS
438
DELISTED
WNS Holdings
WNS
| $15.1M | 0.04% |
256,275
-68,342
| -21% | -$4.17M |
|
|
CBM
439
DELISTED
Cambrex Corporation
CBM
| $15M | 0.04% |
252,906
-149,218
| -37% | -$7.99M |
|
|
TPTX
440
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
| $15M | 0.04% |
400,000
+109,600
| +38% | +$4.77M |
|
|
AVLR
441
DELISTED
Avalara, Inc.
AVLR
| $15M | 0.04% |
222,500
-15,335
| -6% | -$1.24M |
|
442
Hershey
HSY
$34.2B
| $14.9M | 0.04% |
96,417
+83,024
| +620% | +$12.5M |
|
443
Freshpet
FRPT
$3.01B
| $14.9M | 0.04% |
300,000
-13,633
| -4% | -$623K |
|
444
KB Home
KBH
$3.04B
| $14.9M | 0.04% |
437,944
-226,491
| -34% | -$6.34M |
|
445
Fortinet
FTNT
$126B
| $14.8M | 0.04% |
965,130
-77,520
| -7% | -$1.26M |
|
446
Southwest Gas
SWX
$6.29B
| $14.7M | 0.04% |
161,822
-33,064
| -17% | -$2.97M |
|
447
Teledyne Technologies
TDY
$27.7B
| $14.7M | 0.04% |
45,747
+29,210
| +177% | +$8.72M |
|
448
Sun Communities
SUI
$14.3B
| $14.6M | 0.04% |
98,308
-44,572
| -31% | -$6.29M |
|
449
Edison International
EIX
$21B
| $14.5M | 0.04% |
192,102
-239,138
| -55% | -$17.2M |
|
450
Sanofi
SNY
$102B
| $14.4M | 0.04% |
311,240
-8,388
| -3% | -$362K |
|
Similar funds
Federated Hermes's Q3 2019 Portfolio in Review
As of Q3 2019, Federated Hermes held 2,385 positions worth $40.7B, down 1.2% from $41.2B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Federated Hermes's Q3 2019 filing shows 223 new, 794 increased, 1,083 reduced and 195 closed positions. Its largest new stake was Medallia, Inc.: 852,063 shares worth $23.4M. The largest sale was Crown Castle, an estimated $427M.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 16% a quarter earlier, followed by Technology and Financials.
- Federated Hermes's largest Q3 2019 buy was Medallia, Inc.: 852,063 shares worth $23.4M.
- Federated Hermes added most to Gilead Sciences in Q3 2019, an estimated $348M increase.
- Federated Hermes's biggest Q3 2019 reduction was Crown Castle, cutting an estimated $427M.
- Federated Hermes fully exited Worldpay, Inc. in Q3 2019, selling an estimated $194M.
- Federated Hermes's ten largest holdings make up 17% of its $40.7B portfolio in Q3 2019.
- Federated Hermes opened 223 new positions and closed 195 in Q3 2019.
- Federated Hermes's portfolio value fell 1.2% quarter-over-quarter to $40.7B.
Based on Federated Hermes's 13F filing for Q3 2019, filed 14 Nov 2019.